PRIME MEDICINE, INC.

Analyst Reco. Prime Medicine, Inc.

Equities

PRME

US74168J1016

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
6.66 ^USD	+3.74%		+19.57%	-24.83%

May. 13	JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating	MT
May. 10	Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating	May. 13	MT
Chardan Initiates Prime Medicine With Buy Rating, Price Target is $17	Apr. 22	MT
Chardan Initiates Prime Medicine at Buy With $17 Price Target	Apr. 22	MT
Wedbush Initiates Prime Medicine With Outperform Rating, $12 PT; Notes Positive Long-Term Outlook on Gene Editing Platform	Apr. 03	MT
Guggenheim Cuts Prime Medicine's Price Target to $20 From $24, Maintains Buy Rating	Mar. 05	MT
Morgan Stanley Cuts Price Target on Prime Medicine to $12 From $18, Keeps Equalweight Rating	Dec. 12	MT
BMO Capital Starts Prime Medicine at Outperform, $19 Price Target	23-10-09	MT
Jones Trading Starts Prime Medicine at Buy With $20 Price Target	23-09-06	MT
Morgan Stanley Adjusts Price Target on Prime Medicine to $19 From $21, Keeps Equalweight Rating	23-08-14	MT
Guggenheim Starts Prime Medicine at Buy With $24 Price Target	23-07-31	MT
Stifel Initiates Prime Medicine at Hold With $18 Price Target	23-04-18	MT
Morgan Stanley Adjusts Price Target on Prime Medicine to $21 From $23, Maintains Equal-Weight Rating	23-01-24	MT
Goldman Sachs Starts Prime Medicine at Neutral With $22 Price Target	22-11-14	MT
JPMorgan Starts Prime Medicine at Overweight With $27 Price Target	22-11-14	MT
Jefferies Starts Prime Medicine at Buy With $25 Price Target	22-11-14	MT
Morgan Stanley Starts Prime Medicine at Equalweight With $23 Price Target	22-11-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW